v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Mar. 31, 2026
Current assets:    
Cash and cash equivalents $ 289.9 $ 269.2
Restricted cash and cash equivalents 32.1 75.2
Restricted short-term investments — Asbestos 212.9 198.5
Accounts and other receivables, net 499.6 517.3
Inventories 612.1 635.7
Prepaid expenses and other current assets 101.8 120.0
Assets held for sale 10.8 10.9
Total current assets 1,759.2 1,826.8
Property, plant and equipment, net 3,051.4 3,084.6
Operating lease right-of-use assets 130.3 133.4
Finance lease right-of-use assets 97.7 100.8
Goodwill 4,775.8 4,780.4
Intangible assets, net 3,260.5 3,340.1
Deferred income taxes 71.3 73.3
Deferred income taxes — Asbestos 276.3 282.5
Other assets 70.9 66.7
Total assets 13,493.4 13,688.6
Current liabilities:    
Accounts payable and accrued liabilities 699.6 712.5
Accrued payroll and employee benefits 124.7 167.9
Operating lease liabilities 33.6 32.9
Finance lease liabilities 6.3 5.6
Long-term debt, current portion 43.8 43.8
Accrued product warranties 11.1 10.7
Income taxes payable 26.5 13.1
Asbestos liability 128.8 128.3
Other liabilities 35.1 42.6
Total current liabilities 1,109.5 1,157.4
Long-term debt 4,232.9 4,491.2
Deferred income taxes 426.3 399.7
Operating lease liabilities 109.5 114.3
Finance lease liabilities 95.9 97.9
Accrued product warranties 53.9 53.3
Asbestos liability 851.4 880.3
Other liabilities 73.4 69.0
Total liabilities 6,952.8 7,263.1
Commitments and contingencies (Note 11)
Shareholders’ equity:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 580,354,409 shares issued and outstanding at June 30, 2026 and 580,174,308 shares issued and outstanding at March 31, 2026 326.8 326.7
Additional paid-in capital 4,329.4 4,315.4
Retained earnings 1,934.0 1,829.7
Accumulated other comprehensive loss (49.6) (46.3)
Total shareholders’ equity 6,540.6 6,425.5
Total liabilities and shareholders’ equity $ 13,493.4 $ 13,688.6